Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource rightarrow Blocking Peptide rightarrow AKT1  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
separator
ELISA Kit ELISA Kit
CLIA Kit CLIA Kit
PCR Kit PCR Kit
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
siRNA siRNA
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
separator
Our Best Sellers moreseparator
separator
 • apolipoprotein B mRNA editing enzyme, catalytic polypeptide-... Antibody
 • Matrix Metalloproteinase 9 (MMP9) Antibody
 • 5-hydroxytryptamine receptor 2C (HTR2C) Recombinant Protein
 • Bmf (NT) Antibody
 • ACAT1 Antibody
 • Aquaporin 1 (AQP-1) ELISA Kit
 • QuickTiter HBV Core Antigen ELISA Kit
 • Cathepsin K (CTSK) Recombinant Protein
 • Goat anti Rabbit IgG (H + L) (Poly-HRP40) Poly-HRP
 • Fumonisin B1 Toxin
 • RBBP4 Antibody
 • 17-Alpha Hydroxylase (S17AH) ELISA Kit
 • eNOS Antibody
 • Pesticidal crystal protein cry1Fb Recombinant Protein
 downarrow more ...
separator
separator
DatasheetFull DatasheetPrinter Friendly DatasheetPrint This DatasheetAdd to Compare ListHave Questions? Ask UsRequest for a Quotation today

AKT1 blocking peptide :: AKT Blocking Peptide

Scan QR to view Datasheet Catalog #    MBS8244263 AKT1 blocking peptide
Unit / Price
1 mg  /  $195 +1 FREE 8GB USB
5 mg  /  $435 +1 FREE 8GB USB
 
 Go to:   rightarrow  Product Names   rightarrow Product Info   rightarrow Accession #s   rightarrow Product Desc   rightarrow Diseases/Tissues/Pathways   rightarrow Applications   rightarrow References 
 Product Name   

AKT (AKT1), Blocking Peptide

★Popular Item★
 Also Known As   

AKT (pT450) Blocking Peptide

 Product Synonym Names    PKB; RAC; RAC-alpha serine/threonine-protein kinase; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha
 Product Gene Name   

AKT1 blocking peptide

[Similar Products]
 Antibody/Peptide Pairs    AKT peptide (MBS8244263) is used for blocking the activity of AKT antibody (MBS8241866)
 Research Use Only    For Research Use Only. Not for use in diagnostic procedures.
Table BarTOPTable Bar
 OMIM    114480
 3D Structure    ModBase 3D Structure for P31749
Section Bar
 Host    Synthetic
 Species Reactivity    Human, Mouse, Rat, Bovine, Pig, Sheep
Section Bar
 Purity/Purification    >85%
 Form/Format    Lyophilized Powder
Section Bar
 Quality Control    The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.
Section Bar
 Preparation and Storage    Shipped at 4 degree C. Store at -20 degree C for one year.
 Other Notes    Small volumes of AKT1 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Table BarTOPTable Bar
 

Related Product Information for AKT1 blocking peptide

   The peptide is used to block Anti-AKT reactivity.
 Applications Tested/Suitable for AKT1 blocking peptide   

Blocking (BL)

 Application Notes for AKT1 blocking peptide    Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 degree C for overnight or at room temperature for 2 hours.
Table BarTOPTable Bar
NCBI/Uniprot data below describe general gene information for AKT1. It may not necessarily be applicable to this product.
 NCBI GI #    60391226
 NCBI GeneID    207
 NCBI Accession #    P31749.2 [Other Products]
Section Bar
 UniProt Primary Accession #    P31749 [Other Products]
 UniProt Secondary Accession #    Q9BWB6; B2RAM5; B7Z5R1 [Other Products]
 UniProt Related Accession #    P31749 [Other Products]
 Molecular Weight    48,347 Da
Table BarTOPTable Bar
 NCBI Official Full Name    RAC-alpha serine/threonine-protein kinase
 NCBI Official Synonym Full Names    v-akt murine thymoma viral oncogene homolog 1
 NCBI Official Symbol    AKT1 [Similar Products]
 NCBI Official Synonym Symbols   
AKT; PKB; RAC; CWS6; PRKBA; PKB-ALPHA; RAC-ALPHA
[Similar Products]
 NCBI Protein Information    RAC-alpha serine/threonine-protein kinase
 UniProt Protein Name    RAC-alpha serine/threonine-protein kinase
 UniProt Synonym Protein Names   
Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha
 Protein Family    AKT-interacting protein
 UniProt Gene Name    AKT1 [Similar Products]
 UniProt Synonym Gene Names    PKB; RAC; PKB; PKB alpha [Similar Products]
 UniProt Entry Name    AKT1_HUMAN
Section Bar
 NCBI Summary for AKT1    The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]
Section Bar
 UniProt Comments for AKT1    Akt1: an oncogenic AGC kinase that plays a critical role in regulating cell survival and metabolism in many different signaling pathways. Dual phosphorylation is required for its activation. T308 is phosphorylated by PDK1 in the PI3 kinase pathway, and S473 is phosphorylated by mTOR in the mTORC2 pathway. The 'Lys-63'-linked ubiquitination of AKT1 by TRAF6 is important for its translocation to the plasma membrane, phosphorylation, and activation. When Akt is fully phosphorylated it translocates into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its proteosomal degradation. Hyperactive or overexpressed in a number of cancers including breast, prostate, lung, pancreatic, liver, ovarian and colorectal. Over 160 protein substrates are known including many that regulate transcription, metabolism, apoptosis, cell cycle, and growth.

Protein type: Kinase, protein; Oncoprotein; Protein kinase, AGC; EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family

Chromosomal Location of Human Ortholog: 14q32.32

Cellular Component: cytoplasm; cytosol; intercellular junction; microtubule cytoskeleton; mitochondrion; nucleoplasm; nucleus; plasma membrane; spindle; vesicle

Molecular Function: ATP binding; enzyme binding; GTPase activating protein binding; identical protein binding; kinase activity; nitric-oxide synthase regulator activity; phosphatidylinositol-3,4,5-triphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; protein binding; protein kinase activity; protein kinase C binding; protein phosphatase 2A binding; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity

Biological Process: activated T cell apoptosis; aging; apoptosis; apoptotic mitochondrial changes; blood coagulation; cell differentiation; cell projection organization and biogenesis; cell proliferation; cellular response to insulin stimulus; endocrine pancreas development; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; G-protein coupled receptor protein signaling pathway; G1/S-specific positive regulation of cyclin-dependent protein kinase activity; gene expression; germ cell development; glucose homeostasis; glucose metabolic process; glucose transport; glycogen biosynthetic process; hyaluronan metabolic process; inflammatory response; innate immune response; insulin receptor signaling pathway; insulin-like growth factor receptor signaling pathway; lipopolysaccharide-mediated signaling pathway; maternal placenta development; myelin maintenance in the peripheral nervous system; negative regulation of apoptosis; negative regulation of autophagy; negative regulation of caspase activity; negative regulation of cell size; negative regulation of fatty acid beta-oxidation; negative regulation of JNK cascade; negative regulation of protein kinase activity; negative regulation of proteolysis; nerve growth factor receptor signaling pathway; nitric oxide biosynthetic process; nitric oxide metabolic process; osteoblast differentiation; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; phosphoinositide-mediated signaling; phosphorylation; platelet activation; positive regulation of blood vessel endothelial cell migration; positive regulation of cell growth; positive regulation of cellular protein metabolic process; positive regulation of endodeoxyribonuclease activity; positive regulation of endothelial cell proliferation; positive regulation of fat cell differentiation; positive regulation of glucose import; positive regulation of glycogen biosynthetic process; positive regulation of lipid biosynthetic process; positive regulation of nitric oxide biosynthetic process; positive regulation of nitric-oxide synthase activity; positive regulation of peptidyl-serine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein amino acid phosphorylation; positive regulation of transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasoconstriction; programmed cell death; protein amino acid autophosphorylation; protein amino acid phosphorylation; protein catabolic process; protein import into nucleus, translocation; protein kinase B signaling cascade; protein modification process; protein ubiquitination; regulation of cell migration; regulation of glycogen biosynthetic process; regulation of mRNA stability; regulation of myelination; regulation of nitric-oxide synthase activity; regulation of translation; response to DNA damage stimulus; response to food; response to heat; response to oxidative stress; signal transduction; spinal cord development; striated muscle cell differentiation; T cell costimulation; transcription initiation from RNA polymerase II promoter; translation; vascular endothelial growth factor receptor signaling pathway

Disease: Breast Cancer; Cowden Syndrome 6; Ovarian Cancer; Proteus Syndrome; Schizophrenia
Table BarTOPTable Bar
 Research Articles on AKT1    1. The intracellular localization of Akt plays an important role in breast cancer stem-like cells.
Table BarTOPTable Bar
 Precautions    All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
 Disclaimer    While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Table BarTOPTable Bar
Products associated with AKT1 blocking peptidePathways associated with AKT1 blocking peptide
 Reference Product  PubMed Publications
 PTEN blocking peptide  >602 publications with AKT1 and PTEN
 MTOR blocking peptide  >535 publications with AKT1 and MTOR
 GSK3B blocking peptide  >155 publications with AKT1 and GSK3B
 FOXO1 blocking peptide  >152 publications with AKT1 and FOXO1
 NOS3 blocking peptide  >129 publications with AKT1 and NOS3
 FOXO3 blocking peptide  >73 publications with AKT1 and FOXO3
 MDM2 blocking peptide  >56 publications with AKT1 and MDM2
 ILK blocking peptide  >37 publications with AKT1 and ILK
 RICTOR blocking peptide  >29 publications with AKT1 and RICTOR
 HSP90AA1 blocking peptide  >5 publications with AKT1 and HSP90AA1
 Products by Pathway  Pathway Diagram
 AGE-RAGE Signaling Pathway In Diabetic Complications antibodies  AGE-RAGE Signaling Pathway In Diabetic Complications Diagram
 AGE-RAGE Signaling Pathway In Diabetic Complications antibodies  AGE-RAGE Signaling Pathway In Diabetic Complications Diagram
 AGE/RAGE Pathway antibodies  AGE/RAGE Pathway Diagram
 AKT Phosphorylates Targets In The Cytosol Pathway antibodies  AKT Phosphorylates Targets In The Cytosol Pathway Diagram
 AKT Phosphorylates Targets In The Nucleus Pathway antibodies  AKT Phosphorylates Targets In The Nucleus Pathway Diagram
 AKT-mediated Inactivation Of FOXO1A Pathway antibodies  AKT-mediated Inactivation Of FOXO1A Pathway Diagram
 AMPK Signaling Pathway antibodies  AMPK Signaling Pathway Diagram
 AMPK Signaling Pathway antibodies  AMPK Signaling Pathway Diagram
 AMPK Signaling Pathway antibodies  AMPK Signaling Pathway Diagram
 Activation Of BAD And Translocation To Mitochondria Pathway antibodies  Activation Of BAD And Translocation To Mitochondria Pathway Diagram
Diseases associated with AKT1 blocking peptideOrgans/Tissues associated with AKT1 blocking peptide
 Disease Name  Pubmed Publications
 Breast Neoplasms Antibodies  >443 publications with AKT1 and Breast Neoplasms
 Necrosis Antibodies  >310 publications with AKT1 and Necrosis
 Lung Neoplasms Antibodies  >263 publications with AKT1 and Lung Neoplasms
 Prostatic Neoplasms Antibodies  >207 publications with AKT1 and Prostatic Neoplasms
 Inflammation Antibodies  >204 publications with AKT1 and Inflammation
 Neoplasms, Experimental Antibodies  >199 publications with AKT1 and Neoplasms, Experimental
 Heart Diseases Antibodies  >162 publications with AKT1 and Heart Diseases
 Colorectal Neoplasms Antibodies  >150 publications with AKT1 and Colorectal Neoplasms
 Liver Diseases Antibodies  >147 publications with AKT1 and Liver Diseases
 Ovarian Neoplasms Antibodies  >143 publications with AKT1 and Ovarian Neoplasms
 Organ/Tissue Name  Pubmed Publications
 Blood Antibodies  >837 publications with AKT1 and Blood
 Muscle Antibodies  >721 publications with AKT1 and Muscle
 Vascular Antibodies  >713 publications with AKT1 and Vascular
 Brain Antibodies  >536 publications with AKT1 and Brain
 Lung Antibodies  >424 publications with AKT1 and Lung
 Heart Antibodies  >328 publications with AKT1 and Heart
 Liver Antibodies  >327 publications with AKT1 and Liver
 Nerve Antibodies  >265 publications with AKT1 and Nerve
 Prostate Antibodies  >253 publications with AKT1 and Prostate
 Bone Antibodies  >189 publications with AKT1 and Bone
Table BarTOPTable Bar
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions